Measured PD-L1 tumor expression varied across the four assay types (χ2 p < 0.001) and across three assay types excluding SP142 (p < 0.001), with no significant difference between 22C3 and 28–8 assays (p = 0.96). The gene discussed is CD274; the disease is neoplasm.